Other Stories

Full Video

WHO approves China’s CanSino COVID-19 vaccine for emergency use Updated: 2022-05-20 05:57:04 KST

The WHO said Thursday that it has granted emergency use authorization for a COVID-19 vaccine made by China's CanSino Biologics.
The UN health agency said that the single-dose vaccine was found to be about 92-percent effective against severe COVID-19 and 64-percent effective in preventing people from getting symptoms of the virus.
The vaccine is recommended for everyone aged 18 and above.
The vaccine is the 11th vaccine overall, and the third Chinese vaccine to be approved by the WHO.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.
weather